Company|BAT Invests in Expansion of Italian Factory, Adding 16 Production Lines for Heated Tobacco and Nicotine Pouches

Sep.15.2025
Company|BAT Invests in Expansion of Italian Factory, Adding 16 Production Lines for Heated Tobacco and Nicotine Pouches
BAT Italy will expand its Trieste plant, adding 16 new production lines for heated tobacco cartridges, nicotine pouches, and nicotine replacement therapy products. The expansion adds 6,300 m² of space, bringing the total to 30,000 m². This is part of BAT’s €500 million five-year investment plan launched in 2023.

Key Points:

 

·Expansion and Recruitment: BAT Italy is adding 16 new production lines at its Trieste production site and plans to hire 150 professionals by 2026.

·Product Positioning: The new production lines will focus on new nicotine products, including heated tobacco cartridges (for the Italian market only), while also expanding production capacity for oral nicotine pouches (sold to 16 European countries) and nicotine replacement therapy (NRT) products.

·Site Expansion: A new 6,300 square meters of production area will be added, and the expanded recycling warehouse will bring the total area to 30,000 square meters, tripling the original planned area.

·Employment and Positions: The project is part of BAT Italy's five-year plan announced in 2024 and is expected to create 2,700 jobs, primarily in manufacturing and engineering.

·Investment Background: The expansion is part of a five-year €500 million investment plan launched in 2023. By 2024, BAT had invested 168 million euros in Italy, created an output value of 30 million euros, and made a profit of 1.6 million euros, all of which had been reinvested in development.

 


 

2Firsts, September 15, 2025 - According to reports from ticonsiglio and ilsole24ore, British American Tobacco (BAT) Italy plans to hire 150 new positions at its Trieste production site through expansion and the introduction of new production lines.

 

BAT Italy has added 16 production lines to the site and expects to complete the recruitment of 150 professionals by 2026.

 

The expansion will be entirely dedicated to the production of new nicotine products, including heated tobacco cartridges, which users can use with specialized heated tobacco devices. These products will be sold exclusively in Italy.

 

These new production lines will also join existing lines for the production of oral nicotine pouches (currently sold in Italy and 15 other European countries) and the recently commissioned production line for nicotine replacement therapy (NRT) products. The expansion will add an additional 6,300 square meters, including the reuse of a disused warehouse in Trieste's Cargo Village, bringing the total area to 30,000 square meters: triple the original industrial plan's 10,000 square meters.

 

As part of its annual plan, BAT Italy announced in 2024 that it would create 2,700 jobs over the next five years. The majority of these future positions are expected to be in the production and manufacturing sector, encompassing roles such as production operators, equipment maintenance, quality control, technicians, engineers, and production process coordinators.

 

The expansion is part of a five-year, €500 million investment plan launched in 2023. According to data analysis, BAT invested €168 million in 2024 alone, generating €30 million in output. Profits reached €1.6 million in the previous fiscal year, all of which were invested in company development.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds Showcases Vuse Pro Flavors and VELO Nicotine Pouches at NACS Show 2026
Reynolds American, a BAT subsidiary, showcased four Vuse Pro flavored e-cigarette pods and its VELO nicotine pouch portfolio at NACS Show 2026. Booth staff confirmed to 2Firsts that the Vuse Pro flavors are sold in the U.S., although they have not received FDA marketing authorization. BAT outlined plans to expand Vuse retail distribution and reported that VELO held a 30.5% year-to-date volume share of the U.S. modern oral nicotine category through August 2026. The booth also featured the newly launched VELO MAX range and merchandising displays combining cigarettes, vaping products and oral nicotine brands.
EXPO
Oct.09
Product | BAT Launches VELO WRKS Nicotine Pouches in Sweden, Introducing Dual-Compartment Cans With Two Flavours
Product | BAT Launches VELO WRKS Nicotine Pouches in Sweden, Introducing Dual-Compartment Cans With Two Flavours
British American Tobacco (BAT)'s VELO brand launched the VELO WRKS nicotine pouch range in Sweden on November 2, 2026. The initial release features three Dual Can variants, each containing two separate flavours in a dual-compartment container. Each can holds 20 slim pouches with 8mg of nicotine per pouch and retails for SEK 52.99. According to VELO, the first release, Drop 1, is limited to 75,000 cans and will remain available until February 2027 or while stocks last. VELO positions WRKS as a platform for testing new product concepts and has introduced an online consumer feedback survey. EU trademark records show BAT applied to register VELO WRKS in March 2026 under Class 34, covering nicotine pouches, e-cigarettes, heated tobacco products and other tobacco-related goods.
product
Nov.03
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Vaping brand PIXL has introduced the PIXL 5K reusable prefilled pod device in the UK, featuring a 2ml prefilled pod and a 4ml refill container with a combined e-liquid capacity of 6ml. The device uses 20mg/ml nicotine salt e-liquid and is advertised to deliver up to approximately 5,000 puffs. Available through UK retailers by August 2026, the PIXL 5K sits alongside the existing 12ml PIXL 8000. The UK's Vaping Products Duty took effect on October 1 at £0.22 per millilitre, producing theoretical duty amounts of £1.32 and £2.64 for the two products' respective full refill sets.
product
Oct.10
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
A U.S. International Trade Commission (USITC) administrative law judge issued an initial determination on October 20, 2026, finding that certain Glas vaping devices, cartridges and components infringed 12 claims across two patents asserted by JUUL, constituting a violation of Section 337 of the Tariff Act of 1930. The judge recommended a limited exclusion order and a cease and desist order against the Glas respondents. Five months earlier, the FDA authorized four Glas e-cigarette pods, including mango, blueberry and two menthol variants. The patent investigation concerns device and cartridge structures and is separate from FDA premarket review. The proposed import restrictions have not become final, and their product-level scope remains unresolved.
company
Nov.05
Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Documents obtained by 2Firsts show that Sweden's Public Health Agency ordered Swedish Match to revise ingredient labels beyond the five ZYN products inspected. The dispute centers on whether flavoring ingredients must be individually disclosed, with Swedish Match citing trade-secret protection and the regulator insisting on full ingredient disclosure. The company faces a conditional penalty of SEK 2 million per month for noncompliance. As of October 22, the agency had received no appeal, despite the company's stated intention to challenge the decision.
Oct.22
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
Japan Tobacco International's Irish business has proposed a €0.25 tax increase on a pack of 20 cigarettes in its pre-Budget 2027 submission, below the €0.50-or-more increases typically imposed in recent Irish budgets. JTI says the proposal could generate around €45 million in additional Exchequer revenue while limiting further movement toward illicit and non-Irish-tax-paid tobacco. Revenue's existing estimate for a comparable €0.25 increase, including pro-rata rises on other tobacco products, is about €18 million for a full year.
JTI
Sep.18 by 2Firsts Perspectives